BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1783633)

  • 21. A comparative study of methyl ester trimethylsilyl, allyldimethylsilyl and tert-butyldimethylsilyl ethers for electron impact mass spectrometry of leukotrienes.
    Steffenrud S; Borgeat P; Evans MJ; Bertrand MJ
    Biomed Environ Mass Spectrom; 1987 Jul; 14(7):313-23. PubMed ID: 2959338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantification of distinct molecular species of the 2-lyso metabolite of platelet-activating factor by gas chromatography-negative-ion chemical ionization mass spectrometry.
    Turk J; Bohrer A; Stump WT; Ramanadham S; Mangino MJ
    J Chromatogr; 1992 Mar; 575(2):183-96. PubMed ID: 1629294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cooperativity between platelet-activating factor and collagen in platelet aggregation.
    Kojima S; Hagiwara H; Soga W; Sekiya F; Saito Y; Inada Y
    Biochem Biophys Res Commun; 1987 Jun; 145(2):915-20. PubMed ID: 3593379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative analysis of platelet activating factor using fast atom bombardment/tandem mass spectrometry.
    Haroldsen PE; Gaskell SJ
    Biomed Environ Mass Spectrom; 1989 Jun; 18(6):439-44. PubMed ID: 2504312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gas chromatographic-mass spectrometric determination of 5-hydroxymethyluracil in human urine by stable isotope dilution.
    Faure H; Incardona MF; Boujet C; Cadet J; Ducros V; Favier A
    J Chromatogr; 1993 Jun; 616(1):1-7. PubMed ID: 8376480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of MK-287, a new platelet-activating factor antagonist, in plasma and serum by gas chromatography chemical ionization mass spectrometry.
    Fisher AL; Morris MJ; Gilbert JD
    Biol Mass Spectrom; 1991 Jul; 20(7):408-14. PubMed ID: 1932155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis of 1-acyl-2-[3H]acetyl-SN-glycero-3-phosphocholine, a structural analog of platelet activating factor, by vascular endothelial cells.
    Mueller HW; Nollert MU; Eskin SG
    Biochem Biophys Res Commun; 1991 May; 176(3):1557-64. PubMed ID: 2039529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of platelet-activating factor by GC-MS after direct derivatization with pentafluorobenzoyl chloride and heptafluorobutyric anhydride.
    Weintraub ST; Lear CS; Pinckard RN
    J Lipid Res; 1990 Apr; 31(4):719-25. PubMed ID: 2351876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative analysis of platelet-activating factor by gas chromatography-negative-ion chemical ionization mass spectrometry.
    Pickett WC; Ramesha CS
    Methods Enzymol; 1990; 187():142-52. PubMed ID: 2233340
    [No Abstract]   [Full Text] [Related]  

  • 30. Production of platelet-activating factor in glomeruli and cultured glomerular mesangial cells.
    Schlondorff D; Goldwasser P; Neuwirth R; Satriano JA; Clay KL
    Am J Physiol; 1986 Jun; 250(6 Pt 2):F1123-7. PubMed ID: 3087218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure elucidation of platelet activating factor derived from human neutrophils.
    Clay KL; Murphy RC; Andres JL; Lynch J; Henson PM
    Biochem Biophys Res Commun; 1984 Jun; 121(3):815-25. PubMed ID: 6430285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Negative ion electrospray and tandem mass spectrometric analysis of platelet activating factor (PAF) (1-hexadecyl-2-acetyl-glycerophosphocholine).
    Harrison KA; Clay KL; Murphy RC
    J Mass Spectrom; 1999 Apr; 34(4):330-5. PubMed ID: 10226361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for production of platelet-activating factor by yeast Saccharomyces cerevisiae cells.
    Nakayama R; Kumagai H; Saito K
    Biochim Biophys Acta; 1994 Mar; 1199(2):137-42. PubMed ID: 8123662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Highly sensitive gas chromatographic--mass spectrometric method for the determination of platelet-activating factor in human blood.
    Yamada K; Asano O; Yoshimura T; Katayama K
    J Chromatogr; 1988 Dec; 433():243-7. PubMed ID: 3235552
    [No Abstract]   [Full Text] [Related]  

  • 35. Analysis of effector cell-derived lyso platelet activating factor by electron capture negative ion mass spectrometry.
    Christman BW; Gay JC; Christman JW; Prakash C; Blair IA
    Biol Mass Spectrom; 1991 Sep; 20(9):545-52. PubMed ID: 1782204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 1-O-hexadec-1'-enyl-2-acetyl-sn-glycero-3-phosphocholine and its biological activity.
    Nakayama R; Yasuda K; Satouchi K; Saito K
    Biochem Biophys Res Commun; 1988 Mar; 151(3):1256-61. PubMed ID: 3355555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet-activating factor.
    Wykle RL; O'Flaherty JT; Thomas MJ
    Methods Enzymol; 1988; 163():44-54. PubMed ID: 3237085
    [No Abstract]   [Full Text] [Related]  

  • 38. Solid-phase extraction and reversed-phase high-performance liquid chromatographic technique for isolation and estimation of platelet activating factor in plasma.
    Salari H
    J Chromatogr; 1986 Oct; 382():89-98. PubMed ID: 3782417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Target analysis of tert-butyldimethylsilyl derivatives of nerve agent hydrolysis products by selectable one-dimensional or two-dimensional gas chromatography-mass spectrometry.
    Seto Y; Tachikawa M; Kanamori-Kataoka M; Sasamoto K; Ochiai N
    J Chromatogr A; 2017 Jun; 1501():99-106. PubMed ID: 28434709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gas chromatography-mass spectrometry of monohydroxyeicosatetraenoic acids as their methyl esters trimethylsilyl, allyldimethylsilyl and tert.-butyldimethylsilyl ethers.
    Steffenrud S; Borgeat P; Salari H; Evans MJ; Bertrand MJ
    J Chromatogr; 1987 May; 416(2):219-35. PubMed ID: 3611255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.